Vioxx Deal Holds Up Even After Appeals Wins: Experts

Merck & Co Inc. crafted its $4.85 billion Vioxx settlement despite winning 12 of 17 jury verdicts over the painkiller. Although appeals courts have recently overturned two of those verdicts, lowered...

Already a subscriber? Click here to view full article